An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty - European Journal of Vascular and Endovascular Surgery
Peripheral Vascular Market: Drug-Coated Balloons Market Growth in 2021
Drug-Eluting Balloon Market to Reach US$ 1,870.60 Mn at a CAGR of 15.6% in 2027 | The Insight Partners
Drug-Coated Balloons Market - Global Outlook and Forecast 2020-2025
The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes - ScienceDirect
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease - ScienceDirect
RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease | tctmd.com
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
Peripheral drug-coated balloons available in the European market | Download Table
Drug-Eluting Balloon Market to Reach US$ 1,870.60 Mn at a CAGR of 15.6% in 2027 | The Insight Partners
Pharmaceutics | Free Full-Text | A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease | HTML
U.S. Drug-Coated Balloons Market Threatened by Reimbursement Cuts and | mddionline.com